Procrastinator's Marathon 2023 Hybrid Program for Pharmacists and Pharmacy Technicians
Dec 10, 2023 Closed Pharmacy
Description
Online registration for the In-Person option has been closed.
Walk-in registration spots are available
This is your last chance to obtain live continuing educational credits for pharmacy license renewal. This knowledge-based continuing education program (offered either in-person or via Webex) will update the participant regarding Continuous Glucose Monitors, Anxiety and Depression, Asthma, 2023 New Drug Update, and Epilepsy. Don't miss this very relevant information!
Co-sponsored by
Agenda
| 8:00am | Registration |
| 9:00am | Continuous Glucose Meters Sarah Steedman, PharmD |
| 10:00am | Depression Update Haley Simkins, PharmD |
| 11:00am | Break |
| 11:15am | Asthma Update Anna Hale, PharmD |
| 12:15pm | Lunch |
| 1:00pm | Weight Loss Medications Allison Fay, PharmD |
| 2:00pm | Epilepsy Update Victor Dostrow, MD, FAES |
| 3:00pm | Adjourn |
Target Audience
Pharmacists and Pharmacy Technicians in all aspects of Pharmacy
Objectives
- Compare features of current continuous glucose monitoring (CGM) devices in order to select the most appropriate device based on patient characteristics. (P/PT)
- Understand the benefits in patient outcomes from CGM use as explained by current clinical literature and guidelines, and identify patients for whom it is appropriate. (P)
- Interpret key glucose data using an ambulatory glucose profile (AGP) in order to guide patient treatment decisions. (P)
- Identify insurance coverage requirements and prescribing essentials for all types of CGMs and patients. (P/PT)
- Identify appropriate first line therapy options for MDD. (P/PT)
- Compare common pharmacologic antidepressant agents based on their unique drug characteristics. (P)
- Understand pertinent drug interactions related to these agents and how to navigate them. (P)
- Determine potential place in therapy for new drugs for these indications. (P/PT)
- State the recommendations for stepwise approach to asthma therapy as recommended by current guidelines. (P/PT)
- Identify the difference in inhaler types and be able to counsel patients on proper use. (P/PT)
- Understand the literature that lead to the change in guidelines to use SMART therapy first line. (P)
- Review epilepsy impact and classification. (P/PT)
- Recognize the limitations of older antiepileptic drugs. (P/PT)
- Outline potential benefits and important adverse effects of some newer antiepileptic drugs. (P)
- Discuss some of the lesser used newer epileptic agents. (P/PT)
- Review the pharmacoeconomic concerns related to newer epileptic agents. (P/PT)
- List some considerations related to stopping antiepileptic drug therapy. (P)
- Review guideline recommendations for the management of obesity. (P)
- Compare current pharmacological interventions for obesity management in adult and pediatric patients. (P)
- Explain insurance coverage, costs, and access for medications for obesity management. (P/PT)
Faculty
- Victor G. Dostrow, MD
- Allie Fay, PharmD
- Anna A. Hale, PharmD
- Haley R. Simkins, PharmD
- Sarah Steedman, PharmD
Brochure / Registration Form
